ACE Market-listed Nova MSC Bhd is leveraging its strong expertise in the healthcare space to drive innovation and digitalisation for integrated cardiac and vascular hospital Cardiac Vascular Sentral Kuala Lumpur (CVSKL) to enhance the patient’s treatment journey.
Yesterday (June 16), the company which is involved in four main business pillars namely, healthcare, digital government, building automation and virtual construction, has solidified its position as a hospital information system (HIS) partner of CVSKL with the unveiling of the CVSKLgo mobile app.
The customised healthcare app which aims to enhance CVSKL’s patient journey in the post-COVID-19 era contains useful features with an easy-to-use user interface (UI) that allows patients to retrieve useful data such as doctors’ information, billing history, schedule of appointments and medical reports easily.
After a simple registration process, registered patients of CVSKL can also readily access features such as the “Health Dashboard” which allows them to view their vital signs (BMI, pulse rate, weight and height) of the last five visits.
“The launch of the CVSKLgo mobile app reflects the combination of innovation, digitalisation and strong understanding of the comprehensive modern care for cardiac and vascular disease patients,” commented CVSKL’s CEO Tan Eng Ghee.
“We want to provide the best experience for the patients … With our first mobile app, this will enhance their overall treatment experience with us.”
One of Malaysia’s first private cardiac and vascular hospitals, CVSKL which opened its doors in November 2017 is backed by a sterling track record of achievements and expertise, specialising in comprehensive modern care for cardiac and vascular disease patients.
Nova MSC group CEO Lai Teik Kin said the company has seen rising demand for customised digital solutions or applications such as the CVSKLgo mobile app.
“It reflects the hospital’s continuous push towards digitalisation to enhance the patients’ experience when seeking treatment at the hospital,” he noted.
“One of the direct benefits of these customised healthcare apps is that they could help save the time of patients and hospital staff to enquire for simple information such as the patients’ past visits.”
By allowing patients to have access to their own health at their fingertips, Lai added this would increase the efficiency of the hospital’s treatment process.
At the close of yesterday’s (June 16) trading, Nova MSC was unchanged at 8 sen with 978,900 shares traded, thus valuing the company at RM94 mil. – June 17, 2022